HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.8.3
  1. Home
  2. /Compound

Dexelvucitabine

HCID 64973
New reaction
Print

Completing data — refresh the page later to see the latest

Basic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
134379-77-4
Standard SMILES
Nc1nc(=O)n([C@H]2C=C[C@@H](CO)O2)cc1F
InChIKey
HSBKFSPNDWWPSL-CAHLUQPWSA-N
Molecular formula
C9H10FN3O3
Average molar mass
227.19 g/mol
Monoisotopic mass
227.07061935

Overview

Dexelvucitabine has been used in trials studying the treatment of HIV Infections and Human Immunodeficiency Virus.

Names & identifiers

Preferred name
Dexelvucitabine
IUPAC
4-amino-5-fluoro-1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidin-2-one
English name
Dexelvucitabine
Molecular formula
C9H10FN3O3
Molecular weight
227.19

Names & synonyms

Dexelvucitabine134379-77-4ReversetD-D4FCINCB-8721DPC-817YZ-817DexelvucitabinaKU8SPJ271Wbeta-D-D4FCDTXSID201586782',3'-Dideoxy-2',3'-didehydro-beta-L-5-fluorocytidine
Show more names
RVTFd4CYZ 817D-D-4FCRA 131423INCB 8721beta-D-D-4FC
2',3'-Dideoxy-2',3'-didehydro-5-fluorocytidinedexelvucitabinumRefChem:585860DPC817DTXCID2081169ACH-126-443beta-d-2',3'-didehydro-2',3'-dideoxy-5-fluorocytidine4-amino-5-fluoro-1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-1,2-dihydropyrimidin-2-one

Database identifiers

CAS
134379-77-4
PubChem CID
64973
DTXSID
DTXSID20158678
ChEMBL
CHEMBL109831
UNII
KU8SPJ271W
Nikkaji
J1.064.022I

Properties

Computed structural propertiesFilling in

XLogP
-1.3
Topological polar surface area
88.2 Ų
Hydrogen bond donors
2
Hydrogen bond acceptors
4
Rotatable bonds
2
Heavy atoms
16
Formal charge
0
Complexity
405

Experimental & physicochemical properties

DrugsPharmaceuticals -> Listed in ZINC15

Physicochemical properties

Boiling point
394.9 · 394.9±52.0 °C(Predicted)
Density
1.66 · 1.66±0.1 g/cm3(Predicted)
storage temp.
-20 °C · Store at -20°C
solubility
0 · DMSO:0.0(Max Conc. mg/mL);0.0(Max Conc. mM)
form
Solid
pka
14.28 · 14.28±0.10(Predicted)
color
White to off-white
FDA UNII
8 SPJ271W · KU8SPJ271W

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 2 items

Inhibitors of reverse transcriptase (RNA-DIRECTED DNA POLYMERASE), an enzyme that synthesizes DNA on an RNA template.

Agents used to treat AIDS and/or stop the spread of the HIV infection. These do not include drugs used to treat symptoms or opportunistic infections associated with AIDS.

Applications

UsesTreatment of HIV-1 and HIV-2 infection.

UsesDexelvucitabine is a nucleoside reverse transcriptase inhibitor (NRTI) which had the potential to inhibit HIV-1 replication. The drug was discontinued due to evidence that it causes damage to the pancreas.

Related reactions

0 records
New reaction record
No related reactions yet

Compound notes

On this pageBasic informationOverviewNames & identifiersPropertiesChemistry & industryRelated reactionsCompound notes